Breakthrough: Winter 2024
Have you read the latest issue of the OIF's Breakthrough newsletter?  OIF National Conference Programs and Resources Fundraising Galas and Events
2024 Accomplishments
Dear Friend, As we near the end of another wonderful year, we are taking a moment to reflect on the
OIF E-Newsletter: December 2024
The December issue of the OIF E-Newsletter is here! Read a letter from OIF CEO Tracy Hart, updates from the
Quality of Life Findings from the IMPACT Survey!
In 2021, the Osteogenesis Imperfecta Foundation (OIF), the Osteogenesis Imperfecta Federation Europe (OIFE), and Mereo BioPharma collaborated closely to launch
Dear Friend,
Dear Friend, On behalf of the OI Foundation Board of Directors and staff, I am proud to say that 2024
Donor Advised Funds Support the OIF Throughout the Year!
The Osteogenesis Imperfecta Foundation would like to thank those that are making donations through their donor advised funds. Your gifts
OIF E-Newsletter: November 2024
The November issue of the OIF E-Newsletter is here! Read about updates from the OIF, OI research, upcoming events, and
OIF E-Newsletter: October 2024
The October issue of the OIF E-Newsletter is here! Read about Updates from the OIF, OI Research, Upcoming Events, and
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in OI
The OI Foundation would like to bring your attention to an update from Ultragenyx! Ultragenyx Receives Breakthrough Therapy Designation for
The OI Foundation is on TikTok!
The OI Foundation is now on TikTok! As part of our commitment to connecting with the OI community and spreading